Growth Metrics

Enanta Pharmaceuticals (ENTA) Profit After Tax (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.66%
Dec 31, 2025 36.16%
Sep 30, 2025 -2.44%
Jun 30, 2025 19.38%
Mar 31, 2025 -1.59%
Dec 31, 2024 22.67%
Sep 30, 2024 -27.21%
Jun 30, 2024 27.28%
Mar 31, 2024 6.74%
Dec 31, 2023 -18.86%
Sep 30, 2023 28.05%
Jun 30, 2023 -3.74%
Mar 31, 2023 -29.92%
Dec 31, 2022 -10.01%
Sep 30, 2022 16.88%
Jun 30, 2022 5.63%
Mar 31, 2022 -11.55%
Dec 31, 2021 -22.42%
Sep 30, 2021 -2.39%
Jun 30, 2021 -8.98%
Mar 31, 2021 -164.71%
Dec 31, 2020 71.62%
Sep 30, 2020 -105.69%
Jun 30, 2020 -137.55%
Mar 31, 2020 -144.67%
Dec 31, 2019 46.26%
Sep 30, 2019 30.63%
Jun 30, 2019 69.75%
Mar 31, 2019 -84.06%
Dec 31, 2018 -5.14%
Sep 30, 2018 35.15%
Jun 30, 2018 61.59%
Mar 31, 2018 7.37%
Dec 31, 2017 -67.97%
Sep 30, 2017 533.28%
Jun 30, 2017 -56.27%
Mar 31, 2017 -8.27%
Dec 31, 2016 -176.36%
Sep 30, 2016 -67.47%
Jun 30, 2016 34.59%
Mar 31, 2016 -106.28%
Dec 31, 2015 350.60%
Sep 30, 2015 140.36%
Jun 30, 2015 -91.59%
Mar 31, 2015 -31.56%
Dec 31, 2014 933.18%
Sep 30, 2014 -110.07%
Jun 30, 2014 1,062.00%
Mar 31, 2014 3.11%
Dec 31, 2013 -20.86%
Sep 30, 2013 -7.37%
Jun 30, 2013 -10.38%
Mar 31, 2013 -117.07%
Dec 31, 2012 641.88%
Sep 30, 2012 -15.74%
Jun 30, 2012 -110.90%